CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Clinical trials for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) explained in plain language.
Never miss a new study
Get alerted when new CLINICAL HIGH RISK FOR PSYCHOSIS (CHR) trials appear
Sign up with your email to follow new studies for CLINICAL HIGH RISK FOR PSYCHOSIS (CHR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could CBD oil prevent psychosis? major trial launches
Disease control Not yet recruitingThis study tests whether cannabidiol (CBD), a non-psychoactive cannabis compound, can reduce psychotic symptoms in 586 people aged 12-35 who are at high risk for psychosis. Participants take CBD or a placebo daily for 2 years, with regular check-ups and biomarker tests. The goal …
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: PHASE3 • Sponsor: University of Oxford • Aim: Disease control
Last updated May 26, 2026 06:06 UTC
-
Mindfulness may stop psychosis before it starts – major trial launches
Prevention Not yet recruitingThis study tests whether group mindfulness therapy can reduce distress and prevent psychosis in 270 young adults (ages 18–30) who are at ultra-high risk. Participants will either receive mindfulness sessions plus usual care, or usual care alone, and be followed for 6 months. The …
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Prevention
Last updated May 26, 2026 06:07 UTC
-
Can a phone app lift mood in schizophrenia? new study aims to find out
Symptom relief Not yet recruitingThis study tests whether a brief mobile app can help improve mood and reduce negative thinking in 100 people with schizophrenia or at clinical high risk for psychosis. Participants will use the app and report changes in defeatist beliefs and negative symptoms. The goal is to see …
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated May 26, 2026 06:05 UTC
-
Brain scans aim to uncover early signs of psychosis
Knowledge-focused Not yet recruitingThis study uses brain scans to examine dopamine, a brain chemical linked to psychosis, in 115 people aged 18-30 who are at high risk for developing psychosis. Participants will have PET and MRI scans and be followed for up to two years to see if they develop psychosis. The goal i…
Matched conditions: CLINICAL HIGH RISK FOR PSYCHOSIS (CHR)
Phase: PHASE1 • Sponsor: New York State Psychiatric Institute • Aim: Knowledge-focused
Last updated May 26, 2026 06:11 UTC